BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Lynk Pharmaceuticals Secures 322 Million RMB in Series C2 Funding

This round of financing was jointly participated by the Shaoxing Binhai New Area Biomedical Industry Equity Investment Fund managed by China Grand Prosperi...

September 22, 2023 | News

Asieris Pharmaceuticals' APL-1702 Achieves Key Milestone in Cervical HSIL Treatment Trial

Asieris Pharmaceuticals (Stock Code: 688176.SH), a global biopharma company specializing in discovering, developing and commercializing innovative drugs fo...

September 21, 2023 | News

WuXi XDC Launches New Commercial Manufacturing Facilities

New commercial facilities offer one-stop manufacturing services for antibody intermediates, bioconjugate drug substance and drug product Do...

September 21, 2023 | News

Everest Medicines Collaborates with Kezar Life Sciences to Develop Zetomipzomib in Greater China and other Asian Markets

"We are glad to form a partnership with Kezar through our cooperation on zetomipzomib, which will add to our existing renal pipeline, and help solidify Eve...

September 21, 2023 | News

China's NMPA Recommends Priority Review for Cefepime-Taniborbactam in UTI Treatment

"Currently, the clinical challenges from multi-drug resistant infections are severe. The recommendation of priority review by CDE for cefepime-taniborbacta...

September 20, 2023 | News

Cytiva expands scientific, digital, and training offering in China

The facility will host training for more than triple the current number of people per year. The upgraded Fast Trak center will support novel therapy dev...

September 18, 2023 | News

Porton Advanced and BRL Medicine Partner to Fast-Track Gene and Cell Therapy Commercialization

BRL Medicine, with its strong gene editing technology, robust R&D capabilities, and prospective pipelines, has been devoted to the realm of CGT for yea...

September 15, 2023 | News

Cure Genetics and Frametact Strike $60M Deal for Familial Neurological Disease Gene Therapy

The partnership will leverage Cure Genetics' proprietary VELP™ platform to develop novel Adeno-Associated Virus (AAV) vectors for the treatment of fa...

September 15, 2023 | News

BioRay's Zuberitamab (Anruixi®) First Domestic Anti-CD20 Antibody Approved in China

In preclinical studies, Anruixi® showed stronger antibody-dependent cell-mediated cytotoxicity (ADCC), a larger volume of distribution at steady state,...

September 14, 2023 | News

MGI Launches the DCS Lab Initiative to Expand Global Omics Access and Capabilities

"We are proud that through the DCS Lab Initiative, MGI technology and innovation will empower researchers and scientists in achieving their next breakthrou...

September 12, 2023 | News

Genesis MedTech Unveils China's First NPMA-Approved Antibacterial Sutures

The newly developed antibacterial sutures are coated with triclosan, a broad-spectrum antimicrobial agent with activity against gram-positive and...

September 12, 2023 | News

Mabwell and WuXi XDC Forge Long-Term ADC Partnership for Biologics Expansion

Mabwell has had multiple innovative products in clinical studies or preclinical research by their world-leading ADC technology platforms and CMC developmen...

September 11, 2023 | News

iotaSciences and Quantum Design China Enter into Distribution Agreement

iotaSciences, the Oxford-based leader in the rapidly growing field of single-cell handling solutions, and Quantum Design China, a subsidiary of Quantum Des...

September 07, 2023 | News

Brii Biosciences Reports Phase 2 Results for BRII-179 in Hepatitis B Combo Treatment

The cohort level unblinded data from the study demonstrated that in the intent to treat analysis at Week 24 (end of treatment or EoT), 26.3% (15 pa...

September 07, 2023 | News

Stay Connected